AMO unveils new silicone Tecnis IOL

Article

Advanced Medical Optics (AMO) announced the launch of the Tecnis CL intraocular lens (IOL) at the XXIV congress of the ESCRS.

Advanced Medical Optics (AMO) announced the launch of the Tecnis CL intraocular lens (IOL) at the XXIV congress of the ESCRS.

The new lens features blue modified C PMMA haptics for improved visibility and easier implantation, frosted OptiEdge design for reduced edge glare and reduced posterior capsule opacification and highly biocompatible silicone. The Tecnis CL can be implanted using the UNFOLDER Silver Series Implantation Systems and the Silver Advanced Cartridge through a 2.8 mm incision.

The new lens acts as a permanent replacement to the Z9000 and Z9001 Tecnis silicone IOL models.

In August of this year, the US Centers for Medicare and Medicaid Services (CMS) extended New Technology Intraocular Lens (NTIOL) status to the lens. Tecnis and Tecnis CL are the only FDA approved IOLs that are indicated for reducing spherical equivalent, improving visual function and improving night driving performance.

The Tecnis CL is now available in Europe and AMO intends to start shipping the lens to the US, Canada and Asia Pacific within the next month and to Japan by mid-2007.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.